Singapore, Oct. 10 -- AstraZeneca will invest $4.5 billion in its new manufacturing facility in Virginia, US, a proposed increase of $500 million to support the enhanced manufacturing capability of a broader range of medicines including cancer treatments.

This is part of the historic$50 billion investment announced in July 2025. The new facility will be located at Rivanna Futures in Albemarle County and is expected to create approximately 3,600 direct and indirect jobs, powering economic growth and Virginia's leadership at the forefront of life sciences innovation.

The manufacturing facility is expected to create 600 highly skilled jobs in Virginia including engineers, scientists, process facilitators which includes an additional 100 jo...